Cargando…

Melatonin Treatment in Kidney Diseases

Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Markowska, Magdalena, Niemczyk, Stanisław, Romejko, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047594/
https://www.ncbi.nlm.nih.gov/pubmed/36980179
http://dx.doi.org/10.3390/cells12060838
_version_ 1785013964655034368
author Markowska, Magdalena
Niemczyk, Stanisław
Romejko, Katarzyna
author_facet Markowska, Magdalena
Niemczyk, Stanisław
Romejko, Katarzyna
author_sort Markowska, Magdalena
collection PubMed
description Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endocrine derangements. The purpose of this review is to provide information regarding the potential benefits of melatonin use, particularly in kidney diseases. The impact on the cardiovascular system, diabetes, and homeostasis causes melatonin to be indirectly connected to kidney function and quality of life in people with chronic kidney disease. Moreover, there are numerous reports showing that melatonin plays a role as an antioxidant, free radical scavenger, and cytoprotective agent. This means that the supplementation of melatonin can be helpful in almost every type of kidney injury because inflammation, apoptosis, and oxidative stress occur, regardless of the mechanism. The administration of melatonin has a renoprotective effect and inhibits the progression of complications connected to renal failure. It is very important that exogenous melatonin supplementation is well tolerated and that the number of side effects caused by this type of treatment is low.
format Online
Article
Text
id pubmed-10047594
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100475942023-03-29 Melatonin Treatment in Kidney Diseases Markowska, Magdalena Niemczyk, Stanisław Romejko, Katarzyna Cells Review Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endocrine derangements. The purpose of this review is to provide information regarding the potential benefits of melatonin use, particularly in kidney diseases. The impact on the cardiovascular system, diabetes, and homeostasis causes melatonin to be indirectly connected to kidney function and quality of life in people with chronic kidney disease. Moreover, there are numerous reports showing that melatonin plays a role as an antioxidant, free radical scavenger, and cytoprotective agent. This means that the supplementation of melatonin can be helpful in almost every type of kidney injury because inflammation, apoptosis, and oxidative stress occur, regardless of the mechanism. The administration of melatonin has a renoprotective effect and inhibits the progression of complications connected to renal failure. It is very important that exogenous melatonin supplementation is well tolerated and that the number of side effects caused by this type of treatment is low. MDPI 2023-03-08 /pmc/articles/PMC10047594/ /pubmed/36980179 http://dx.doi.org/10.3390/cells12060838 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Markowska, Magdalena
Niemczyk, Stanisław
Romejko, Katarzyna
Melatonin Treatment in Kidney Diseases
title Melatonin Treatment in Kidney Diseases
title_full Melatonin Treatment in Kidney Diseases
title_fullStr Melatonin Treatment in Kidney Diseases
title_full_unstemmed Melatonin Treatment in Kidney Diseases
title_short Melatonin Treatment in Kidney Diseases
title_sort melatonin treatment in kidney diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047594/
https://www.ncbi.nlm.nih.gov/pubmed/36980179
http://dx.doi.org/10.3390/cells12060838
work_keys_str_mv AT markowskamagdalena melatonintreatmentinkidneydiseases
AT niemczykstanisław melatonintreatmentinkidneydiseases
AT romejkokatarzyna melatonintreatmentinkidneydiseases